Home › Funds › Atle Fund Management AB › ALKS

Atle Fund Management AB position in ALKS

ALKERMES PLC · Health Care

Atle Fund Management AB reported holding 136,225 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 1.48% of its reported portfolio and ranking #26 among its reported holdings. Atle Fund Management AB has disclosed ALKS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)136.22K sh
Reported value held$5.52M
Portfolio Weight1.48%
First reportedQ2 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's ALKS position evolved

Atle Fund Management AB first disclosed a stake in ALKS in Q2 2024 at 68,800 shares (US$1.7M). The position peaked in Q2 2026 at 213,329 shares, worth US$11.2M. Across 10 filings, Atle Fund Management AB increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 136,225 shares valued at US$5.5M — a reduction of -77,104 shares quarter over quarter.. Notable position changes include a 244% increase in Q3 2024 (shares rose 3% over the following quarter), a 36% trim in Q3 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 68.80K $1.66M New
Q3 2024 236.61K $6.62M Add
Q4 2024 266.50K $7.67M Add
Q1 2025 214.78K $7.09M Reduce
Q2 2025 227.22K $6.50M Add
Q3 2025 252.88K $805.39K Add
Q4 2025 242.47K $6.78M Reduce
Q1 2026 242.47K $8.24M Hold
Q2 2026 213.33K $11.18M Reduce
Q3 2026 136.22K $5.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALKS and 13F data

ALKS (ALKERMES PLC) is a Health Care company. 43 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$338.5M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALKS

All ALKS fund holders →

FAQ

How long has Atle Fund Management AB held ALKS?

Atle Fund Management AB has disclosed ALKS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Atle Fund Management AB's current position in ALKS?

As of Q3 2026, Atle Fund Management AB holds 136.22K shares of ALKS (ALKERMES PLC), valued at $5.52M, representing 1.48% of its reported portfolio and ranking #26.

Has Atle Fund Management AB been buying or selling ALKS?

In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in ALKS. The position peaked in Q2 2026 at 213.33K shares.

Which other funds hold ALKS?

Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.